Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Year-over-year book value per share growth
Percentile
P64
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -8.77% |
| Q3 2025 | 95.06% |
| Q2 2025 | -5.42% |
| Q1 2025 | -9.87% |
| Q4 2024 | -11.71% |
| Q3 2024 | -13.03% |
| Q2 2024 | 83.52% |
| Q1 2024 | -33.75% |
| Q4 2023 | 194.41% |
| Q3 2023 | 70.31% |
| Q2 2023 | 326.76% |
| Q1 2023 | -74.52% |
| Q4 2022 | -32.08% |
| Q3 2022 | -25.78% |
| Q2 2022 | -56.16% |
| Q1 2022 | 48.48% |
| Q4 2021 | -12.04% |
| Q3 2021 | -26.41% |
| Q2 2021 | -27.02% |
| Q1 2021 | -17.61% |
| Q4 2020 | -5.15% |
| Q3 2020 | -50.35% |
| Q2 2020 | 472.58% |
| Q1 2020 | -41.56% |
| Q4 2019 | -22.45% |
| Q3 2019 | 7.47% |
| Q2 2019 | -41.46% |
| Q1 2019 | -44.81% |
| Q4 2018 | 103.44% |
| Q3 2018 | -14.85% |
| Q2 2018 | -33.96% |
| Q1 2018 | -13.25% |
| Q4 2017 | -43.39% |
| Q3 2017 | -14.42% |
| Q2 2017 | -52.64% |
| Q1 2017 | 825.79% |
| Q4 2016 | -64.70% |
| Q3 2016 | 115.62% |
| Q2 2016 | -57.37% |
| Q1 2016 | 80.97% |